Clinical Assistant in Neurology, St. Helier Hospital, Carshalton
Sanomigran for Migraine Prophylaxis; Controlled Multicenter Trial in General Practice
Article first published online: 23 JUN 2005
Headache: The Journal of Head and Face Pain
Volume 17, Issue 3, pages 109–112, July 1977
How to Cite
Lawrence, E.R., Hossain, M. and Littlestone, W. (1977), Sanomigran for Migraine Prophylaxis; Controlled Multicenter Trial in General Practice. Headache: The Journal of Head and Face Pain, 17: 109–112. doi: 10.1111/j.1526-4610.1977.hed1703109.x
- Issue published online: 23 JUN 2005
- Article first published online: 23 JUN 2005
- Accepted for Publication: 41977.
- Cited By
Pizotifen, a tricyclic antiserotonin agent and inhibitor of certain other biogenic amines, was effective in reducing the severity and frequency of migraine attacks, producing complete remission in some cases, in a double-blind placebo controlled trial in 36 patients. Serious side effects were not reported during the trial period.